CRS Founders Award

Criteria:
The individual must be internationally recognized for outstanding scientific or technological contributions in the field of delivery of bioactives. Membership in the CRS is required.

Nomination Process:
Nominations must be in writing. Nominations may be submitted by a member of CRS.

Letters of nomination must include an abbreviated curriculum vitae and two letters of support for the nominee. These required documents must be sent to Linda Schmitt no later than January 31, 2010.

Selection Process:
The Founders Award Committee will make the selection of the awardee.

Award:
The awardee will receive:

• Special Award
• Complimentary Annual Meeting and Exposition Registration
• Complimentary ticket to the closing banquet
• $5000 Cash Award
• Award Winner to Give a Presentation at the 37th CRS Annual Meeting & Exposition

Notification:
Awardee will be notified no later than April 15, 2010.

CRS - Founders' Award 2010 Winner
Vladimir P. Torchilin, Ph.D., D.Sc. is a distinguished professor of pharmaceutical sciences and director of the Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA. He graduated from Moscow University with an M.S. degree in chemistry and also obtained there his Ph.D. and D.Sc. degrees in polymer chemistry, chemical kinetics and catalysis, and chemistry of physiologically active compounds in 1971 and 1980, respectively. In 1991 Dr. Torchilin joined Massachusetts General Hospital and Harvard Medical School as the head of the Chemistry Program, Center for Imaging and Pharmaceutical Research, and associate professor of radiology. Since 1998 Dr. Torchilin has been with Northeastern University. He was the chair of the Department of Pharmaceutical Sciences from 1998 to 2008. His research interests have focused on biomedical polymers, polymeric drugs, immobilized medicinal enzymes, drug delivery and targeting, pharmaceutical nanocarriers for diagnostic and therapeutic agents, and experimental cancer immunology. He has published more than 300 original papers and more than 100 reviews and book chapters, has written and edited 10 books, including Immobilized Enzymes in Medicine, The Handbook on Targeted Delivery of Imaging Agents, Liposomes: A Practical Approach, Nanoparticulates as Pharmaceutical Carriers, Multifunctional Pharmaceutical Nanocarriers, Biomedical Aspects of Drug Targeting, and Delivery of Protein and Peptide Drugs in Cancer, and holds more that 40 patents. He is editor-in-chief of Current Drug Discovery Technologies, co-editor-in-chief of Drug Delivery and is a member of the editorial boards of many leading journals in the field, including the Journal of Controlled Release (review editor), Bioconjugate Chemistry, Advanced Drug Delivery Reviews, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Drug Targeting, Molecular Pharmaceutics, Journal of Biomedical Nanotechnology, and a few others. Among his many awards, Prof. Torchilin was the recipient of the 1982 Lenin Prize in Science and Technology (the highest scientific award in the former USSR). He was elected as a member of the European Academy of Sciences. He is also a Fellow of the American Institute of Medical and Biological Engineering and the American Association of Pharmaceutical Scientists (AAPS) and received the 2005 Research Achievements in Pharmaceutics and Drug Delivery Award from AAPS, 2007 Research Achievements Award from the Pharmaceutical Sciences World Congress, 2009 AAPS Journal Award, 2009 International Journal of Nanomedicine Distinguished Scientist Award, and 2010 Controlled Release Society Founders Award. In 2005–2006 he served as president of the Controlled Release Society.